key: cord-0725469-a85dlqqb authors: Verma, Ashish; Patel, Ankit B.; Tio, Maria Clarissa; Waikar, Sushrut S. title: Caring for Dialysis Patients in a Time of COVID-19 date: 2020-10-14 journal: Kidney Med DOI: 10.1016/j.xkme.2020.07.006 sha: 75cda85846430c9797044a6237f9578add89a254 doc_id: 725469 cord_uid: a85dlqqb Coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a pandemic and a public health emergency. The overwhelming rise in the number of cases has brought significant challenges to healthcare systems worldwide. Patients with end-stage kidney disease (ESKD) are highly vulnerable with the multiple comorbidities that make them susceptible to adverse outcomes with COVID-19. Over 2 million people worldwide receive maintenance hemodialysis (HD) at outpatient centers. Effectively preventing the spread of infection among HD centers, healthcare personnel, and patients is essential to ensure the continued delivery of dialysis to ESKD patients. This article discusses dialysis patients' care during COVID-19, addressing measures for patient and health care personnel protection and care of dialysis patients with suspected or confirmed COVID-19. Coronavirus 2019 (COVID-19) is a respiratory illness that started in Wuhan, China, and has now spread to more than 150 countries, including the United States 1 . As of July 14 th , the total number of confirmed COVID-19 cases has reached 13,145,302 worldwide 2 . Patients with COVID-19 infection usually present with fever (44%-98%), cough (68%-76%), myalgia (18%), and fatigue (18%) 3 . The overwhelming rise in the number of cases has challenged healthcare systems all over the world. The estimated case fatality risk for COVID-19 ranges from 0.25% to 3%, 4 with the risks higher in those with preexisting comorbid conditions-10.5% for cardiovascular disease, 7.3% for diabetes, 6.3% for chronic respiratory disease, 6.0% for hypertension, and 5.6% for cancer 55 5 . In 2016, nearly 125,000 people in the United States were initiated on kidney replacement therapy (KRT) for End-Stage Kidney Disease (ESKD), with over 726,000 on dialysis or living with a kidney transplant 6 . Dialysis patients receive KRT through various modalities including incenter hemodialysis (HD), peritoneal dialysis, and home HD. In the United States, 62.7% of ESKD patients receive HD as their KRT modality, with 98% of them receiving treatments in outpatient centers. Patients on KRT have multiple comorbidities such as diabetes, hypertension, and cardiovascular disease, which are risk factors for adverse outcomes in COVID- 19 . In addition, patients on KRT who are infected with SARS-CoV-2 usually present with atypical symptoms, making it a diagnostic challenge 7 .The second patient who died from COVID-19 in the United States was a outpatient HD patients from the Seattle area 8, 9 . The experiences of frontline nephrologists caring for dialysis patients in Seattle and New York have been described recently 9, 10 . Scope of the problem J o u r n a l P r e -p r o o f SARS-CoV-2 spreads from person to person through droplets expelled during coughing and sneezing 1 . Transmission through direct contact and fecal contamination can also occur 1 . Recent reports show that aerosol transmission is also possible 11 . Patients on HD are a particularly unique and vulnerable population in the COVID-19 pandemic. HD patients cannot practice social distancing as they receive HD treatments routinely at least three times a week at outpatient dialysis units. Each session requires traveling to and from the outpatient group and inevitable exposures to healthcare personnel and all the patients concurrently receiving treatment in a particular session. At any given shift, more than 20 patients can be treated. To continue providing usual care for these patients, a framework to protect patients and healthcare personnel from contracting and spreading COVID-19 needs to be in place. In response to this, the American Society of Nephrology (ASN), together with the Centers for Disease Control and Prevention (CDC), established a COVID-19 response team. This response team has laid out guidelines for all HD facilities to follow, especially in caring for patients under investigation (PUI) and patients with COVID-19. In this review, we discuss the best practices on how to care for patients with known or suspected COVID-19 in the outpatient HD setting, how to protect patients and healthcare personnel from disease exposure using personal protective equipment, and how to approach a patient on HD with confirmed COVID-19. Patients with COVID-19 can be asymptomatic or symptomatic 2-14 days following exposure 1 High-risk exposure is defined as having prolonged close contact with COVID-19 patients with the healthcare personnel not wearing PPE with nose and mouth exposed to droplets potentially carrying the virus. Medium-risk exposure is defined as having prolonged close contact with COVID-19 patients while wearing a face mask while the nose and mouth were potentially exposed to material that may contain the virus. Low-risk exposure is defined as having brief interactions with patients with COVID-19 or prolonged close contact with patients wearing a facemask for source control while the healthcare personnel was wearing a facemask or respirator. An healthcare personnel deemed to be high or medium risk will be instructed to selfquarantine for 14 days. An healthcare personnel considered to have had low-risk exposure can continue to work and self-monitor for symptoms, including twice-a-day temperature checks, with instructions to stop working if fever or respiratory symptoms develop. The healthcare personnel should then self-quarantine and subsequently update the dialysis facility about disease course. transmission-based isolation should discontinue after the resolution of fever without feverreducing medications and improvement in respiratory symptoms and negative results of a molecular assay for COVID-19 from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart as test-based strategy 16 . Per non-test-based strategy transmission-based protocol, the isolation should discontinue when at least three days have passed since recovery defined as resolution of respiratory symptoms, and at least seven days have passed since symptoms first appeared 16 . Box 1 shows guidance for discontinuing home isolation for HCP and transmission-based protocol for patients. When these patients are ready to discharge from the hospitals, appropriate planning and allocation to the outpatient dialysis unit should be done. Isolation should be maintained at home if the patient gets discharged before the removal of the transmission-based protocol. If a patient is discharged to a long-term care facility or assisted living facility before discontinuing the transmission-based protocol, it should continue at the discharge facility. If a patient is discharged to a long term care or assisted care facility following stop of transmission-based protocol and J o u r n a l P r e -p r o o f still has symptoms, then he or she should be kept in an isolation room wearing masks all day for a total of 14 days after onset of illness or resolution of symptoms 16 . Both primary teams and nephrologists need to be aware of the importance of appropriate discharge planning for this vulnerable patient population. If discharge occurs before removing transmission-based precautions, the patient would be expected to maintain social distancing at home for the remaining time. Arrangements should be made regarding where the patient would continue outpatient dialysis sessions, usually in COVID-19 designated facilities, if available. Excellent communication with outpatient units is essential to ensure the patients' smooth transition to receiving their regular treatments upon discharge. If a patient were to be discharged to long-term care or assisted living facility, the facility must provide regular dialysis treatments. Contact precautions should be in place in the facility if the patient were to continue the remainder of transmission-based precautions. Once the precautions are lifted, but the patient remains symptomatic, the patient must be kept in an isolation room while wearing a mask for a total duration of 14 days after the onset of illness or upon the resolution of symptoms. Table 1 shows the clinical outcomes data of clinical studies in hemodialysis patients with COVID-19. Peritoneal dialysis and home hemodialysis patients can also be impacted by COVID-19 though there is limited information related to this. As both of these groups of patients can complete their renal replacement therapy at home, this minimizes risks of exposure and allows them to practice social distancing. It is vital to prevent any interruptions with the delivery of supplies to those on home dialysis treatments. Over 100,000 Americans have been initiated on KRT annually since 2002. In standard practice, preparing patients for KRT initiation requires months of lead-time, to include education on KRT modalities, frequent outpatient nephrology visits for medication titration, appointments with respective surgical subspecialties for access evaluation, necessary imaging, surgery for access creation, and ample time to allow for access to mature. As non-urgent outpatient visits are deferred, and elective surgeries and procedures are being canceled during the pandemic, it is essential to highlight that CKD Stage 5 patients nearing KRT are an extremely vulnerable group. On March 26, 2020, the Centers for Medicare and Medicaid Services announced that access creation for ESKD patients remains an essential procedure 17 . In reality, these necessary procedures may still suffer delays when resources become scarce in the setting of the pandemic. It is necessary to recognize that while resource allocation will be challenging, crash-start dialysis or unprepared dialysis is associated with poorer outcomes, higher mortality, and a significantly negative socioeconomic impact. The COVID-19 pandemic has resulted in a strain on both dialysis facilities and patients. Dialysis facilities may have to arrange different dialysis shifts for patients under investigation. J o u r n a l P r e -p r o o f Box 1. Guidance for discontinuing home isolation for HCP and transmission-based protocol for patients 14, 16 . Test based strategy * • Resolution of fever without the use of fever-reducing medications and • Improvement in respiratory symptoms (e.g., cough, shortness of breath) and • Negative results of an FDA Emergency Use Authorized molecular assay for COVID-19 from at least two consecutive nasopharyngeal swab specimens collected ≥24 hours apart. According to exposure, healthcare personnel will classify into high, medium and low risk exposure categories High or medium risk exposure 1) Put on surgical mask 2) Practice self quarantine for 14 days 3) Report diagnostic test results to the supervisor Low risk exposure 1) Continue working per protocol. 2) Check temperature twice a day and report to dialysis in charge. 3) Stop working and put on surgical mask even after new mild symptoms of fever, cough and shortness of breath. 4) Practice self quarantine for 14 days and report diagnostic test result to the dialysis facility in charge Coronavirus disease 2019 (COVID-19): situation summary Clinical Characteristics of Coronavirus Disease 2019 in China Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality. Emerging Infectious Disease journal Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention Coronavirus Disease 2019 (COVID-19) Pneumonia in a Hemodialysis Patient Dialysis Should Continue Despite COVID-19 On the Frontline of the COVID-19 Outbreak. Keeping Patients on Long-Term Dialysis Safe Management of hemodialysis patients with suspected or confirmed COVID-19 infection: perspective of two nephrologists in the United States Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 Lessons from the Experience in Wuhan to Reduce Risk of COVID-19 Infection in Patients Undergoing Long-Term Hemodialysis Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease (COVID-19) Discontinuation of Home Isolation for Persons with COVID-19 (Interim Guidance) Twice-Weekly Hemodialysis Is an Option for Many Patients in Times of Dialysis Unit Stress Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance). Vol 20202020. 17. End Stage Renal Disease (ESRD) Facilities: CMS Flexibilities to Fight COVID-19 Epidemiology of COVID-19 in an Urban Dialysis Center A report from the Brescia Renal COVID Task Force on the clinical characteristics and short-term outcome of hemodialysis patients with SARS-CoV-2 infection Chronic Hemodialysis Patients Hospitalized with COVID-19 -Short-term Outcomes in Bronx Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan